MAXHEALTH Share Price Target 2050

CAGR-based price projection for Max Healthcare Institute Limited (MAXHEALTH) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (-0.5% CAGR)
Rs 830
2050 Target
Base Case (-1.3% CAGR)
Rs 687
2050 Target
Bull Case (-2.0% CAGR)
Rs 586
2050 Target

Current Market Snapshot

CMP: Rs 940.95
52W High: Rs 1,153.40
52W Low: Rs 929.80
1Y CAGR: -2.6%
3Y CAGR: -1.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 936 Rs 929 Rs 923
2028 Rs 931 Rs 917 Rs 905
2029 Rs 926 Rs 905 Rs 887
2030 Rs 922 Rs 893 Rs 870
2031 Rs 917 Rs 881 Rs 853
2032 Rs 912 Rs 870 Rs 836
2033 Rs 907 Rs 859 Rs 820
2034 Rs 902 Rs 847 Rs 804
2035 Rs 898 Rs 836 Rs 788
2036 Rs 893 Rs 825 Rs 773
2037 Rs 888 Rs 815 Rs 758
2038 Rs 884 Rs 804 Rs 743
2039 Rs 879 Rs 794 Rs 728
2040 Rs 875 Rs 783 Rs 714
2041 Rs 870 Rs 773 Rs 700
2042 Rs 866 Rs 763 Rs 687
2043 Rs 861 Rs 753 Rs 673
2044 Rs 857 Rs 743 Rs 660
2045 Rs 852 Rs 734 Rs 647
2046 Rs 848 Rs 724 Rs 634
2047 Rs 843 Rs 715 Rs 622
2048 Rs 839 Rs 705 Rs 610
2049 Rs 835 Rs 696 Rs 598
2050 Rs 830 Rs 687 Rs 586

Other MAXHEALTH Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the MAXHEALTH share price target for 2050?

Based on historical growth analysis, the MAXHEALTH share price target for 2050 ranges from Rs 830 (conservative) to Rs 687 (base case) to Rs 586 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of MAXHEALTH?

The current market price of MAXHEALTH (Max Healthcare Institute Limited) is Rs 940.95. The 52-week high is Rs 1,153.40 and 52-week low is Rs 929.80.

Is MAXHEALTH a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for MAXHEALTH price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -0.5% CAGR), Base (-1.3% CAGR), and Bull (optimistic at -2.0% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.